Denali Therapeutics

Denali Therapeutics is a biotechnology company dedicated to defeating neurodegenerative conditions by engineering medicines that cross the blood-brain barrier. The enterprise utilizes its proprietary Transport Vehicle platform to deliver enzymes, oligonucleotides, and antibodies across the brain’s vascular endothelium to treat Alzheimer’s disease, Parkinson’s disease, and lysosomal storage disorders. Through translational neurobiology and transport engineering, Denali Therapeutics develops targeted therapies for previously impenetrable central nervous system targets.